CNS Pharmaceuticals Announces it Has No Exposure to Silicon Valley Bank Issues

HOUSTON, March 13, 2023 /PRNewswire/ — CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it is…

Leave a Reply

Your email address will not be published. Required fields are marked *